Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use
Background: Psoriasis is a chronic inflammatory disease that has a negative impact on patients' quality of life. Patients with mild–moderate psoriasis can be treated with topical medications, such as the combination drug calcipotriol/betamethasone dipropionate (Cal/BD). Objectives: This st...
Main Authors: | Francisco J. Navarro-Triviño, Mario Lozano-Lozano, Ricardo Ruiz-Villaverde |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2021-05-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | http://dpcj.org/index.php/dpc/article/view/1595 |
Similar Items
-
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
by: Anderko M, et al.
Published: (2019-09-01) -
Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis
by: Kim A. Papp, et al.
Published: (2022-10-01) -
Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reports
by: Zoe Apalla, et al.
Published: (2022-07-01) -
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
by: Pinter A, et al.
Published: (2018-10-01) -
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE)
by: Sascha Gerdes, et al.
Published: (2021-11-01)